Vidhu Mathur

Annexon Biosciences (United States) — United States

Neuroscience · Life Sciences

16h-index3.2kcitations34works8.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroinflammation and Neurodegeneration Mechanisms(13), Alzheimer's disease research and treatments(4), Prion Diseases and Protein Misfolding(4), Retinal Diseases and Treatments(3), Neurogenesis and neuroplasticity mechanisms(3)

Publications34 total

Analyzing the Birth, Propogation and Toxicity of Yeast Prions.
Figshare·2025Open Access
Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain
Nature Communications·2025· 16 citedOpen Access
Novel small molecules therapeutics for FTD/ALS reduce TDP43 related pathology
Alzheimer s & Dementia·2023Open Access
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease
Ophthalmology Science·2023· 24 citedOpen Access
Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates
Investigative Ophthalmology & Visual Science·2023· 10 citedOpen Access
Inhibiting C1q Improves Compound Muscle Action Potential and Reduces Neuronal Damage in the SOD1G93A Mouse Model (P1-13.004)
Neurology·2022· 2 cited
Inhibition of C1q Reduces Nerve Damage as Measured by Neurofilament Light Chain in the HD R6/2 Mouse Model (S36.004)
Neurology·2022· 2 cited
Complement protein C1q is a therapeutic target for neuropathic pain
2021· 2 citedOpen Access
Ageing hallmarks exhibit organ-specific temporal signatures
Yearbook of pediatric endocrinology·2021· 26 cited
Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury
Science·2021· 121 citedOpen Access
I11 Pharmacologic inhibition of the classical complement pathway enhances neuronal function and HD R6/2 mouse survival
2021· 1 cited
The Experiences, Challenges and Acceptance of Online Food Application by the Consumers and the Enhancement of Value Through Blockchain Technology
Asia-Pacific Journal of Management Research and Innovation·2021
Pharmacokinetics and target engagement of intravitreal administration of ANX007, an anti-C1q antibody fragment, in nonhuman primates
Investigative Ophthalmology & Visual Science·2021· 3 citedOpen Access
Acute and late administration of colony stimulating factor 1 attenuates chronic cognitive impairment following mild traumatic brain injury in mice
Brain Behavior and Immunity·2021· 17 citedOpen Access
Author Correction: Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
Nature Neuroscience·2020· 24 citedOpen Access
Ageing hallmarks exhibit organ-specific temporal signatures
Nature·2020· 649 citedOpen Access
Complement factor C1q mediates chronic neuron loss and inflammation post-brain injury
2020Open Access
Author Correction: Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
Nature Neuroscience·2020· 19 citedOpen Access
Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
Nature Neuroscience·2020· 1.3k citedOpen Access
Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain
2019· 73 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Benoit Lehallier(10), Ted Yednock(10), Tony Wyss‐Coray(9), Yaisa Andrews‐Zwilling(9), Sethu Sankaranarayanan(8), Macy E. Zardeneta(7), Song Eun Lee(7), Oliver Hãhn(7), Tal Iram(5), Michael S. Haney(5), Ellen Cahir-McFarland(5), Julia Marschallinger(4), John V. Pluvinage(4), David W. Morgens(4), Justin Kim(4), Julia Tevini(4), Thomas K. Felder(4), Heimo Wolinski(4), Carolyn R. Bertozzi(4), Michael C. Bassik(4)